Homologous and heterologous serological response to the N‐terminal domain of SARS‐CoV‐2 in humans and mice

The increasing numbers of infected cases of coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) poses serious threats to public health and the global economy. Most SARS‐CoV‐2 neutralizing antibodies target the receptor binding domain (RBD) and s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur J Immunol
Asıl Yazarlar: Lv, Huibin, Tsang, Owen Tak‐Yin, So, Ray T. Y., Wang, Yiquan, Yuan, Meng, Liu, Hejun, Yip, Garrick K., Teo, Qi Wen, Lin, Yihan, Liang, Weiwen, Wang, Jinlin, Ng, Wilson W., Wilson, Ian A., Peiris, J. S. Malik, Wu, Nicholas C., Mok, Chris K. P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2021
Konular:
Immunity to infection
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8237060/
https://ncbi.nlm.nih.gov/pubmed/34089541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eji.202149234
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller